Late prematurity still carries risks

Article

Babies arriving 4 to 6 weeks early are significantly more likely to develop respiratory distress syndrome, sepsis, intraventricular hemorrhage, hypoglycemia, and jaundice requiring phototherapy

A recent retrospective study of spontaneous, low-risk, singleton, late preterm (between 34 and 37 weeks' gestation) deliveries finds that, compared with full-term infants, the babies arriving 4 to 6 weeks early were significantly more likely to develop respiratory distress syndrome (4.2% vs. 0.1%, P<.001), sepsis (0.4% vs. 0.04%, P<.001), intraventricular hemorrhage (0.2% vs. 0.02%, P<.001), hypoglycemia (6.8% vs. 0.4%, P<.001), and jaundice requiring phototherapy (18% vs. 2.5%, P<.001). The study, conducted in Israel, included almost 2,500 late preterm babies and almost 7,500 full-term controls.

The authors report that the relationship between gestational age and neonatal morbidity is of a continuous nature with a nadir at about 39 weeks' gestation. The relationship does not, as previously believed, have a term–preterm threshold, nor is it related to birthweight. They also found that among late-preterm babies, risk factors that further increase morbidity risk include cesarean delivery, male sex, and parity.

The authors concluded that given the short- and long-term neonatal morbidity, hospitalization days, and costs associated with late prematurity, practitioners may want to consider doing more to prolong pregnancy when spontaneous preterm labor occurs beyond 34 weeks' gestation.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.